Trademark: 79386352
Word
ZEVIPTO
Status Date
Thursday, August 15, 2024
Filing Date
Wednesday, November 8, 2023
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the above with the exception of pharmaceuticals for the prevention and treatment of central nervous system diseases and disorders
Jan 17, 2024
New Application Office Supplied Data Entered
Jan 18, 2024
Assigned To Examiner
Dec 28, 2023
Sn Assigned For Sect 66a Appl From Ib
Dec 29, 2023
Limitation From Original Application Entered
Jan 23, 2024
Application Filing Receipt Mailed
Jan 24, 2024
Non-Final Action Written
Jan 25, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Feb 5, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 5, 2024
Teas Change Of Domestic Representatives Address
Feb 5, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 5, 2024
Teas Change Of Correspondence Received
Feb 5, 2024
Teas Change Of Owner Address Received
Feb 5, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 13, 2024
Refusal Processed By Mpu
Feb 13, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Aug 15, 2024
Petition To Revive-Granted
Aug 15, 2024
Notice Of Revival - E-Mailed
Aug 15, 2024
Teas Petition To Revive Received
Aug 15, 2024
Teas Response To Office Action Received
Mar 5, 2024
Refusal Processed By Ib
Trademark Alertz updated from USPTO on 2030-01-24
